Growth in prescription costs unsustainable
-$321 billion (2011) expected to approach $.5 trillion by 2016
-Threatens the pharmacy benefit
Pharmaceutical marketing programs highly effective
-Over $10 billion annually on free samples to physicians
-“Me-too” brand alternatives replace use of cost-effective generic medications
Generics represent the largest opportunity to control prescription costs
-Provides option for first-line therapy at significant $ savings
-BUT, lacks marketing channel and educational support
Consumer driven healthcare initiatives
-Patient centric benefit design (HAS / HRA)
-Consumers empowered with cost – service – quality equation
Medication errors under focus
-Pharmaceutical sampling valued by physicians and patients
-Prescribing and sampling process lack controls
To learn more how SampleRx can assist your organization manage escalating pharmacy expenditures, we invite you to contact us.